Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)
Also known as: Epstein-Barr Virus-Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD) / EBV-Related Post-Transplant Lymphoproliferative Disorder / EBV+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD) / EBV+ Post-transplant Lymphoproliferative Disease (EBV+ PTLD) / EBV-Related PTLD / Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorder
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB09035 | Nivolumab | 1 | Completed | 1 |
DB15419 | Nanatinostat | 2 | Recruiting | 1 |
DB00073 | Rituximab | 2 | Active Not Recruiting | 1 |
DB17072 | Tabelecleucel | 2 | Recruiting | 1 |
DB01610 | Valganciclovir | 2 | Recruiting | 1 |
DB17072 | Tabelecleucel | 3 | Completed | 1 |
DB17072 | Tabelecleucel | 3 | Recruiting | 1 |
DB17072 | Tabelecleucel | Not Available | No Longer Available | 1 |